Critical Therapeutics raising $54M
Critical Therapeutics of Lexington, Massachusetts, plans to raise $54.5 million in a private stock sale with a part of the funds going to relaunch its Zyflo asthma drug, acquired from Abbott last year. The launch is expected in the second half of this year. Other funds will go to advance its pipeline drugs.
- read this story from the AP for more
Paid Research Reports
- RNA therapy: the next big thing after monoclonal antibodies?
- Biotech M&A Strategies: Deal assessments, trends and future prospects
- The Dermatology Market Outlook to 2013: Competitive landscape, pipeline analysis and growth opportunities
- Pipeline Insight: Cancer Overview - Breast, Gynecological, Genitourinary - Diverse drugs approaching the market for many tumor t
- Sales Force Effectiveness
